Machine Learning to Refine Selection Criteria of PostOperative Radiotherapy for Resectable Stage III-N2 NonSmall Cell Lung Cancer

被引：0
|
作者：
Zarinshenas, R. [1 ]
Ladbury, C. J. [1 ]
Mcgee, H. M. [1 ]
Raz, D. [2 ]
Erhunmwunsee, L. [2 ,3 ]
Pathak, R. [4 ]
Glaser, S. M. [1 ]
Salgia, R. [4 ]
Williams, T. M. [1 ]
Amini, A. [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Radiat Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Surg, 1500 E Duarte Rd, Duarte, CA 91010 USA
[3] City Hope Natl Med Ctr, Dept Populat Sci, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2893
引用
收藏
页码：E400 / E400
页数：1
相关论文
共 50 条
  • [21] Postoperative radiotherapy and lung cancer in stage III: helpful or harmful
    Fiorica, Francesco
    JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : E277 - E278
  • [22] Postoperative radiotherapy for elderly patients with stage III lung cancer
    Wisnivesky, Juan P.
    Halm, Ethan A.
    Bonomi, Marcelo
    Smith, Cardinale
    Mhango, Grace
    Bagiella, Emilia
    CANCER, 2012, 118 (18) : 4478 - 4485
  • [23] PROGNOSIS OF UNSUSPECTED BUT COMPLETELY RESECTABLE N2 NONSMALL CELL LUNG-CANCER
    VANKLAVEREN, RJ
    FESTEN, J
    OTTEN, HJAM
    COX, AL
    DEGRAAF, R
    LACQUET, LK
    ANNALS OF THORACIC SURGERY, 1993, 56 (02): : 300 - 304
  • [24] Postoperative Radiation Therapy Should Not Be Used for the Therapy of Stage III-N2 NSCLC
    Faivre-Finn, Corinne
    Edwards, John G.
    Hatton, Matthew
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (02) : 197 - 199
  • [25] A prospective randomized study of adjuvant chemotherapy in completely resected stage III-N2 non small cell lung cancer
    Wang Si-yu
    Ou Wei
    Lin Yong-Bin
    Liang Ying
    Ye Xiong
    Zhang Bin-Bin
    Yang Hua
    CHINESE JOURNAL OF CANCER RESEARCH, 2007, 19 (03) : 189 - 194
  • [26] Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective
    Aigner, Clemens
    Batirel, Hasan
    Huber, Rudolf M.
    Jones, David R.
    Sihoe, Alan D. L.
    Stupnik, Tomaz
    Brunelli, Alessandro
    EUROPEAN RESPIRATORY REVIEW, 2024, 33 (171):
  • [27] Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
    Huber, Rudolf M.
    De Ruysscher, Dirk
    Hoffmann, Hans
    Reu, Simone
    Tufman, Amanda
    EUROPEAN RESPIRATORY REVIEW, 2019, 28 (152):
  • [28] Effect of interfraction interval in hyperfractionated radiotherapy with or without concurrent chemotherapy for Stage III nonsmall cell lung cancer
    Jeremic, B
    Shibamoto, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02): : 303 - 308
  • [29] IMPORTANCE OF BIOLOGIC STATUS TO THE POSTOPERATIVE PROGNOSIS OF PATIENTS WITH STAGE-III NONSMALL CELL LUNG-CANCER
    NAKAHARA, K
    MONDEN, Y
    OHNO, K
    FUJII, Y
    HASHIMOTO, J
    KITAGAWA, Y
    KAWASHIMA, Y
    JOURNAL OF SURGICAL ONCOLOGY, 1987, 36 (03) : 155 - 160
  • [30] Concurrent cisplatin, etoposide, and radiotherapy for unresectable Stage III nonsmall cell lung cancer: A Phase II study
    Reboul, F
    Brewer, Y
    Vincent, P
    Chauvet, B
    Faure, CF
    Taulelle, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (02): : 343 - 350
12345